PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
MDGL vs. VKTX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between MDGL and VKTX is 0.38, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.4

Performance

MDGL vs. VKTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Madrigal Pharmaceuticals, Inc. (MDGL) and Viking Therapeutics, Inc. (VKTX). The values are adjusted to include any dividend payments, if applicable.

100.00%200.00%300.00%400.00%500.00%600.00%700.00%800.00%JulyAugustSeptemberOctoberNovemberDecember
270.28%
371.54%
MDGL
VKTX

Key characteristics

Sharpe Ratio

MDGL:

0.61

VKTX:

0.93

Sortino Ratio

MDGL:

1.39

VKTX:

2.91

Omega Ratio

MDGL:

1.17

VKTX:

1.37

Calmar Ratio

MDGL:

0.68

VKTX:

2.35

Martin Ratio

MDGL:

2.53

VKTX:

4.34

Ulcer Index

MDGL:

15.63%

VKTX:

32.19%

Daily Std Dev

MDGL:

64.36%

VKTX:

150.18%

Max Drawdown

MDGL:

-98.40%

VKTX:

-90.41%

Current Drawdown

MDGL:

-24.74%

VKTX:

-55.29%

Fundamentals

Market Cap

MDGL:

$6.78B

VKTX:

$5.26B

EPS

MDGL:

-$25.03

VKTX:

-$0.94

PEG Ratio

MDGL:

0.00

VKTX:

-0.03

Total Revenue (TTM)

MDGL:

$77.58M

VKTX:

$436.00K

Gross Profit (TTM)

MDGL:

$74.22M

VKTX:

$126.00K

EBITDA (TTM)

MDGL:

-$502.65M

VKTX:

-$133.82M

Returns By Period

In the year-to-date period, MDGL achieves a 33.30% return, which is significantly lower than VKTX's 127.03% return.


MDGL

YTD

33.30%

1M

-2.73%

6M

10.78%

1Y

38.75%

5Y*

28.12%

10Y*

12.97%

VKTX

YTD

127.03%

1M

-18.17%

6M

-19.89%

1Y

122.37%

5Y*

38.53%

10Y*

N/A

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

MDGL vs. VKTX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Madrigal Pharmaceuticals, Inc. (MDGL) and Viking Therapeutics, Inc. (VKTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for MDGL, currently valued at 0.61, compared to the broader market-4.00-2.000.002.000.610.93
The chart of Sortino ratio for MDGL, currently valued at 1.39, compared to the broader market-4.00-2.000.002.004.001.392.91
The chart of Omega ratio for MDGL, currently valued at 1.17, compared to the broader market0.501.001.502.001.171.37
The chart of Calmar ratio for MDGL, currently valued at 0.87, compared to the broader market0.002.004.006.000.872.35
The chart of Martin ratio for MDGL, currently valued at 2.53, compared to the broader market-5.000.005.0010.0015.0020.0025.002.534.34
MDGL
VKTX

The current MDGL Sharpe Ratio is 0.61, which is lower than the VKTX Sharpe Ratio of 0.93. The chart below compares the historical Sharpe Ratios of MDGL and VKTX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.005.00JulyAugustSeptemberOctoberNovemberDecember
0.61
0.93
MDGL
VKTX

Dividends

MDGL vs. VKTX - Dividend Comparison

Neither MDGL nor VKTX has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

MDGL vs. VKTX - Drawdown Comparison

The maximum MDGL drawdown since its inception was -98.40%, which is greater than VKTX's maximum drawdown of -90.41%. Use the drawdown chart below to compare losses from any high point for MDGL and VKTX. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-13.08%
-55.29%
MDGL
VKTX

Volatility

MDGL vs. VKTX - Volatility Comparison

The current volatility for Madrigal Pharmaceuticals, Inc. (MDGL) is 11.87%, while Viking Therapeutics, Inc. (VKTX) has a volatility of 23.90%. This indicates that MDGL experiences smaller price fluctuations and is considered to be less risky than VKTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%30.00%35.00%JulyAugustSeptemberOctoberNovemberDecember
11.87%
23.90%
MDGL
VKTX

Financials

MDGL vs. VKTX - Financials Comparison

This section allows you to compare key financial metrics between Madrigal Pharmaceuticals, Inc. and Viking Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab